A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells

Experimental Neurology

Volumn 201, Issue 1, 2006, Pages 193-202

  Price, Tulin Otamis ^a   Uras, Fikriye ^a   Banks, William A ^b,c   Ercal, Nuran ^c,d  

^a MARMARA UNIVERSITY   (Turkey)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

Antioxidants; Blood brain barrier; gp120 protein; HIV 1; Oxidative stress; Tat protein

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CASPASE 3; CATALASE; CELL ENZYME; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLYCOPROTEIN GP 120; LACTATE DEHYDROGENASE (CYTOCHROME); MALONALDEHYDE; N ACETYLCYSTEINAMIDE; REACTIVE OXYGEN METABOLITE; TETRAZOLIUM; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL IMMORTALIZATION; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; MEASUREMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ACETYLCYSTEINE; ANIMALS; BRAIN; CASPASE 3; CASPASES; CATALASE; CELL LINE; CELL SURVIVAL; ENDOTHELIAL CELLS; GENE PRODUCTS, TAT; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; HIV ENVELOPE PROTEIN GP120; INTRACELLULAR FLUID; MALONDIALDEHYDE; MOLECULAR STRUCTURE; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES;

EID: 33747131064     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.03.030     Document Type: Article

References (64)

1. Aebi H. Catalase in vitro. Methods Enzymol. 105 (1984) 121-126
2. Agarwal R., and Shukla G.S. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem. Res. 24 (1999) 1507-1514
3. Agarwal R., Gupta A., and Shukla G.S. Developmental pattern of reactive oxygen species generation and antioxidative defense machinery in rat cerebral microvessels. Int. J. Dev. Neurosci. 17 (1999) 673-679
4. Annunziata P. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J. Neurol. 250 (2003) 901-906
5. Atlas, D., Melamed, E., Offen, D., 1999, February. Brain targeted low molecular weight hydrophobic antioxidant compounds. U.S. Patent No. 5,874,468.
6. Avison M.J., Nath A., Greene-Avison R., Schmitt F.A., Bales R.A., Ethisham A., Greenberg R.N., and Berger J.R. Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J. Neurovirol. 10 (2004) 223-232
7. Banks W.A. Physiology and pathophysiology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders. J. Neurovirol. 5 (1999) 538-555
8. Banks W.A. Protector, prey, or perpetrator: the pathophysiology of the blood-brain barrier in NeuroAIDS. Sci. Online: NeuroAIDS 3 (2000) 1-6
9. Banks W.A., Freed E.O., Wolf K.M., Robinson S.M., Franko M., and Kumar V.B. Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosis. J. Virol. 75 (2001) 4681-4691
10. Begley D.J. ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 10 (2004) 1295-1312
11. Belghmi K., Nicolas J.C., and Crastes de Paulet A. Chemiluminescent assay of lipid hydroperoxides. J. Biolumin. Chemilumin. 2 (1988) 113-119
12. Bellomo G., Vairetti M., Stivala L., Mirabelli F., Richelmi P., and Orrenius S. Demonstration of nuclear compartmentalization of glutathione in hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4412-4416
13. Bradford M.A. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-256
14. Buttke T.M., and Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol. Today 15 (1994) 7-10
15. Chandra J., Samali A., and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29 (2000) 323-333
16. Cioni C., and Annunziata P. Circulating gp120 alters the blood-brain barrier permeability in HIV-1 gp120 transgenic mice. Neurosci. Lett. 330 (2002) 299-301
17. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326 (1997) 1-16
18. Corasaniti M.T., Bagetta G., Rotiroti D., and Nistico G. The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. Biochem. Pharmacol. 56 (1998) 153-156
19. Cory A.H., Owen T.C., Barltrop J.A., and Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 3 7 (1991) 207-212
20. Davson H., and Segal M.B. Special Aspects of the Blood-Brain Barrier. Physiology of the CSF and Blood-Brain Barriers (1996), CRC Press, Boca Raton, FL 303-485
21. Didier N., Banks W.A., Creminon C., Dereuddre-Bosquet N., and Mabondzo A. HIV-1 induced production of endothelin-1 in an in vitro model of the blood-brain barrier. Neuroreport 13 (2002) 1179-1183
22. Draper H.H., Squires E.J., Mahmoodi H., Wu J., Agarwal M., and Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic. Biol. Med. 15 (1993) 353-363
23. Foga I.O., Nath A., Hasinoff B.B., and Geiger J.D. Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 16 (1997) 223-229
24. Grinberg L., Fibach E., Amer J., and Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic. Biol. Med. 38 (2005) 136-145
25. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
26. Hardebo J.E., and Owman C. Enzymatic barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain barrier. In: Johansson B.B., Owman C., and Widner H. (Eds). Pathophysiology of the Blood-Brain Barrier (1990), Elsevier, Amsterdam 41-55
27. Henderson A., and Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis: potential new use for an old drug. Ann. Pharmacother. 28 (1994) 1086-1088
28. Holdiness M.R. Clinical pharmacokinetics of N-acetylcysteine. Clin. Pharmacokinet. 20 (1991) 123-134
29. Hong W., and Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biol. Med. 27 5-6 (1999) 612-616
30. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9 (1990) 515-540
31. Johanson C.E. The choroid plexus-arachnoid membrane-cerebrospinal fluid system. In: Boulton A.A., Baker G.B., and Walz W. (Eds). Neuromethods: The Neuronal Microenvironment (1988), The Humana Press, Clifton, NJ 33-104
32. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.-H., Shen W.-H., Johnson R.W., and Broussard S.R. Cytokine-induced sickness behavior. Brain, Behav., Immun. 17 (2003) S112-S118
33. Lagrange P., Romero I.A., and Revest P.A. Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. Free Radic. Biol. Med. 27 (1999) 667-672
34. Lipton S.A. Ca2+, N-methyl-d-aspartate receptors, and AIDS-related neuronal injury. Int. Rev. Neurobiol. 36 (1994) 1-27
35. Macho A., Hirsch T., Marzo I., Marchetti P., Dallaporta B., Susin S.A., Zamzami N., and Kroemer G. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J. Immunol. 158 (1997) 4612-4619
36. Miller D.W. Immunobiology of the blood-brain barrier. J. Neurovirol. 5 (1999) 570-578
37. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., and Perno C.F. Oxidative stress and NeuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24 (2001) 411-416
38. Neal R., Matthews R.H., Lutz P., and Ercal N. Antioxidant role of N-acetyl cysteine isomers following high dose irradiation. Free Radic. Biol. Med. 34 (2003) 689-695
39. Nemeth I., and Boda D. The ratio of oxidized/reduced glutathione as an index of oxidative stress in various experimental models of shock syndrome. Biomed. Biochim. Acta 48 (1989) S53-S57
40. Nottet H.S., Persidsky Y., Sasseville V.G., Nukuna A.N., Bock P., Zhai Q.H., Sharer L.R., McComb R.D., Swindells S., Soderland C., and Gendelman H.E. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol. 156 (1996) 1284-1295
41. Offen D., Gilgun-Sherki Y., Barhum Y., Benhar M., Grinberg L., Reich E., Melamed, and Atlas D. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J. Neurochem. 89 (2004) 1241-1251
42. Pan W., and Kastin A.J. Transport of cytokines and neurotrophins across the blood-brain barrier and its regulation after spinal cord injury. In: Sharma H.S., and Westman J. (Eds). Blood-Spinal Cord and Brain Barriers in Health and Disease, Chapter 20 (2003), Academic Press, San Diego 395-407
43. Park I.W., Ullrich C.K., Schoenberger E., Ganju R.K., and Groopman J.E. HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation. J. Immunol. 167 (2001) 2766-2771
44. Penugonda S., Mare S., Goldstein G., Banks W.A., and Ercal N. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Res. 1056 2 (2005) 132-138
45. Persidsky Y., Stins M., Way D., Witte M.H., Weinand M., Kim K.S., Bock P., Gendelman H.E., and Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158 (1997) 3499-3510
46. Plateel M., Dehouck M.P., Torpier G., Cecchelli R., and Teissier E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J. Neurochem. 65 (1995) 2138-2145
47. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., and Trapp B.D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alteration of the blood-brain barrier. Ann. Neurol. 34 (1993) 339-350
48. Price T.O., Ercal N., Nakaoke R., and Banks W.A. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045 (2005) 57-63
49. Rapoport S.I. Blood Brain Barrier in Physiology and Medicine (1976), Raven Press, New York
50. Ridnour L.A., Winters R.A., Ercal N., and Spitz D.R. Measurement of glutathione, glutathione disulfide, and other thiols in mammalian cell and tissue homogenates using high-performance liquid chromatography separation of N-(1-pyrenyl)maleimide derivatives. Methods Enzymol. 299 (1999) 258-267
51. Roux F., Durieu-Trautmann O., Chaverot N., Claire M., Mailly P., Bourre J.M., Strosberg A.D., and Couraud P.O. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol. 159 (1994) 101-113
52. Sandhir R., Julka D., and Gill K. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol. Toxicol. 74 (1994) 66-71
53. Sastre J., Asensi M., Rodrigo F., Pallardo F.V., Vento M., and Vina J. Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat. Life Sci. 54 (1994) 2055-2059
54. Sjodin K., Nilsson E., Hallberg A., and Tunek A. Metabolism of N-acetyl-l-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability. Biochem. Pharmacol. 38 (1989) 3981-3985
55. Sonnerborg A., Carlin G., Akerlund B., and Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scand. J. Infect. Dis. 20 (1988) 287-290
56. Spector R. Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53 (1989) 1667-1674
57. 2-resistant fibroblasts. Arch. Biochem. Biophys. 292 (1992) 221-227
58. Thomas S.A. Anti-HIV drug distribution to the central nervous system. Curr. Pharm. Des. 10 (2004) 1313-1324
59. Toborek M., Lee Y.W., Pu H., Malecki A., Flora G., Garrido R., Hennig B., Bauer H.C., and Nath A. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J. Neurochem. 84 (2003) 169-179
60. Toneatto S., Finco O., van der Putten H., Abrignani S., and Annunziata P. Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13 (1999) 2343-2348
61. Ullrich C.K., Groopman J.E., and Ganju R.K. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 96 (2000) 1438-1442
62. Valles E.G., de Castro C.R., and Castro J.A. N-acetyl cysteine is an early but also a late preventive agent against carbon tetrachloride-induced liver necrosis. Toxicol. Lett. 71 (1994) 87-95
63. Vanella A., Di Giacomo C., Sorrenti V., Russo A., Castorina C., Campisi A., Renis M., and Perez-Polo J.R. Free radical scavenger depletion in post-ischemic reperfusion brain damage. Neurochem. Res. 18 12 (1993 Dec) 1337-1340
64. Wanamarta A.H., van Rijn J., Blank L.E., Haveman J., van Zandwijk N., and Joenje H. Effect of N-acetylcysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung tumor cells. J. Cancer Res. Clin. Oncol. 115 (1989) 340-344